Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Unknown 2Terminated 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 54Thoracic 17Gynecologic 15CNS 13Head & Neck 10Breast 9Sarcoma 7Genitourinary 3Dermatologic 3Other solid neoplasm 2Endocrine 2Tumor-Agnostic 1Other hematologic neoplasm 1NET 1Lymphoid 1

Conditions

Pituitary Neoplasms 1Neuroendocrine Tumors 1Neoplasm Metastasis 1

Interventions

lutetium Lu 177 dotatate 6Everolimus 6lanreotide 5anlotinib 5Temozolomide 5Injections 4Dexmedetomidine 4Cisplatin 4surufatinib 3Thyrotropin Alfa 3Sodium Chloride 3Saline Solution 3Fluorodeoxyglucose F18 3Blood Specimen Collection 3177Lu-octreotide, DOTA(0)-Tyr(3)- 3(177)Lu-DOTA-EB-TATE 3sintilimab 2penpulimab 2cabozantinib 2Surgical Procedures, Operative 2Sorafenib 2Rosiglitazone 2Radiotherapy 2Radiofrequency Ablation 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Nivolumab 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Metformin 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Surgical Procedures, Operative × Endocrine × Clear all
NCT04066322 2019-09-24

RMPanNET

Fudan University

Unknown
180 enrolled
EndocrineNET

Neoplasm Metastasis, Neuroendocrine Tumors

NCT03714763 2018-10-22

Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)

Ruijin Hospital

Phase NA Unknown
50 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡